Literature DB >> 31143578

Growth of Pituitary Macroadenomas Postpartial Resection: Implications for Adjuvant Radiotherapy.

Valerie Panet-Raymond1, Kushraw Sabit1, George Shenouda1, Denis Sirhan2, Anthony Zeitouni3, Luis Souhami1.   

Abstract

Objective  To determine the volumetric growth in macroadenomas (MAs) patients with residual postoperative disease and to identify subpopulations with rapid postoperative growth rate that may benefit from early salvage radiotherapy (RT). Methods  Patients who had undergone a partial resection for MAs and did not receive immediate postoperative RT were eligible. Residual tissue was contoured on serial magnetic resonance imaging and planimetric and volumetric changes in size were measured. Growth rates were established by a single observer using serial volumetric measurements. Data were analyzed to find a relationship among growth rate, adjuvant treatment, and patient and tumor characteristics. Results  Thirty-one patients met the eligibility criteria. Nine patients (29%) required adjuvant treatment because of tumor growth. Volumetric growth was identified 95% of the time compared with 64% planimetrically. Planimetric growth could not be established in 10% of patients showing volumetric changes. Median growth rate was 0.4464 mL/y. Growth rate positively correlated with size of residual postoperative volume ( p  < 0.001). Receiving salvage treatment positively correlated with growth rate ( p  = 0.001), particularly at a rate above 2.19 mL/y ( p  = 0.0064). Five patients (16%) had a growth rate above this level, all of which required salvage treatment. Patients with postoperative residual volume > 3.95 mL were most likely to experience rapid growth rate and require salvage treatment ( p  = 0.007). Conclusion  Volumetric measurement was found to be superior to planimetric measurement in detecting changes in patients with residual tumors. Patients with postoperative residual volume > 3.95 mL should be considered for early treatment with RT.

Entities:  

Keywords:  macroadenoma; pituitary; radiotherapy; surgery; volumetric growth

Year:  2018        PMID: 31143578      PMCID: PMC6534728          DOI: 10.1055/s-0038-1670686

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  10 in total

1.  Non-functioning pituitary adenomas: indications for postoperative radiotherapy.

Authors:  A C Woollons; M K Hunn; Y R Rajapakse; R Toomath; D A Hamilton; J V Conaglen; V Balakrishnan
Journal:  Clin Endocrinol (Oxf)       Date:  2000-12       Impact factor: 3.478

2.  Volumetric measurement of vestibular schwannoma tumour growth following partial resection: predictors for recurrence.

Authors:  Siavosh Vakilian; Luis Souhami; Denis Melançon; Anthony Zeitouni
Journal:  J Neurol Surg B Skull Base       Date:  2012-04

3.  Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?

Authors:  Raghava Reddy; Simon Cudlip; James V Byrne; Niki Karavitaki; John A H Wass
Journal:  Eur J Endocrinol       Date:  2011-09-07       Impact factor: 6.664

4.  Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study.

Authors:  H E Turner; I M Stratton; J V Byrne; C B Adams; J A Wass
Journal:  Clin Endocrinol (Oxf)       Date:  1999-09       Impact factor: 3.478

5.  Radiotherapy for pituitary adenomas: long-term efficacy and toxicity.

Authors:  Sara C Erridge; David S Conkey; Diane Stockton; Mark W J Strachan; Patrick F X Statham; Ian R Whittle; Robin Grant; Gillian R Kerr; Anna Gregor
Journal:  Radiother Oncol       Date:  2009-11-10       Impact factor: 6.280

6.  Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.

Authors:  Y Greenman; G Ouaknine; I Veshchev; I I Reider-Groswasser; Y Segev; N Stern
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

7.  An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation.

Authors:  K M Bradley; C B Adams; C P Potter; D W Wheeler; P J Anslow; C W Burke
Journal:  Clin Endocrinol (Oxf)       Date:  1994-11       Impact factor: 3.478

8.  Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.

Authors:  I Jonathan Pomeraniec; Hideyuki Kano; Zhiyuan Xu; Brandon Nguyen; Zaid A Siddiqui; Danilo Silva; Mayur Sharma; Hesham Radwan; Jonathan A Cohen; Robert F Dallapiazza; Christian Iorio-Morin; Amparo Wolf; John A Jane; Inga S Grills; David Mathieu; Douglas Kondziolka; Cheng-Chia Lee; Chih-Chun Wu; Christopher P Cifarelli; Tomas Chytka; Gene H Barnett; L Dade Lunsford; Jason P Sheehan
Journal:  J Neurosurg       Date:  2017-10-27       Impact factor: 5.115

Review 9.  Nonfunctioning pituitary tumors.

Authors:  Mark E Molitch
Journal:  Handb Clin Neurol       Date:  2014

10.  The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas.

Authors:  Eoin P O'Sullivan; Conor Woods; Nigel Glynn; Lucy Ann Behan; Rachel Crowley; Patrick O'Kelly; Diarmuid Smith; Chris J Thompson; Amar Agha
Journal:  Clin Endocrinol (Oxf)       Date:  2009-03-19       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.